Selected article for: "epidemic transmission and International license"

Author: Gerardo Chowell; Ranu Dhillon; Devabhaktuni Srikrishna
Title: Getting to zero quickly in the 2019-nCov epidemic with vaccines or rapid testing
  • Document date: 2020_2_5
  • ID: 4sw1hrnf_8
    Snippet: symptomatically infected patients within 24 hours of symptom onset (assuming 10% asymptomatic transmission). The epidemic could be ended in six months if testing with isolation and treatment reached 90% of symptomatic patients. If 90% of symptomatic patients could be tested within six hours of symptoms appearing, the epidemic could be ended in under four months. This epidemic could be ended within months if widely usable diagnostics or vaccines c.....
    Document: symptomatically infected patients within 24 hours of symptom onset (assuming 10% asymptomatic transmission). The epidemic could be ended in six months if testing with isolation and treatment reached 90% of symptomatic patients. If 90% of symptomatic patients could be tested within six hours of symptoms appearing, the epidemic could be ended in under four months. This epidemic could be ended within months if widely usable diagnostics or vaccines could be developed and used to cover a sufficient proportion of the at-risk population. . CC-BY-NC-ND 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

    Search related documents:
    Co phrase search for related documents
    • cc NC ND International license and month end: 1, 2
    • cc NC ND International license and risk population: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • cc NC ND International license and symptom onset: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • cc NC ND International license and symptomatic patient: 1
    • cc NC ND International license and treatment isolation: 1, 2, 3, 4
    • epidemic month end and month end: 1, 2, 3, 4, 5
    • International license and month end: 1, 2, 3
    • International license and risk population: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
    • International license and symptom onset: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • International license and symptomatic patient: 1, 2
    • International license and treatment isolation: 1, 2, 3, 4, 5
    • month end and risk population: 1
    • risk population and symptom onset: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20
    • risk population and symptomatic patient: 1, 2
    • risk population and treatment isolation: 1, 2, 3, 4, 5, 6, 7, 8
    • symptom onset and treatment isolation: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20
    • symptomatic patient and treatment isolation: 1, 2, 3, 4